α-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells

Invasion and Metastasis

Volumn 17, Issue 2, 1998, Pages 82-93

  Murata, Jun ^a   Ayukawa, Koichi ^a   Ogasawara, Masaru ^a   Fujii, Hideki ^a,b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

melanocyte stimulating hormone; Invasion; Melanoma; Metastasis; Motility

Indexed keywords

ALPHA INTERMEDIN; FIBRONECTIN; GELATINASE A; GELATINASE B; LAMININ; MATRIGEL;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; LUNG METASTASIS; MELANOMA B16; METASTASIS POTENTIAL; MOUSE; NONHUMAN;

ALPHA-MSH; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; COLLAGEN; CYCLIC AMP; DRUG COMBINATIONS; FEMALE; GELATINASES; LAMININ; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0345628034     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 1980; 283:139-146.
2. Liotta LA: Tumor invasion and metastasis - Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 1986;46:1-7.
3. Stracke ML, Murata J, Aznavoorian A, Liotta LA: The role of the extracellular matrix in tumor cell metastasis. In Vivo 1994;8:49-58.
4. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang ACY, Cohen SN, Numa S: Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor. Nature 1979;278:423-427.
5. Catania A, Lipton JM: α-Melanocyte-stimulating hormone peptides in host responses. Ann NY Acad Sci 1993;680:412-423.
6. Pawelek JM: Studies on the Cloudman melanoma cell lines as a model for the action of MSH. Yale J Biol Med 1985;58:571-578.
7. Verhaagen J, Edwards PM, Jennekens FGI, Schotman P, Gispen WH: α-Melanocyte-stimulating hormone stimulates the outgrowth of myelinated nerve fibers after peripheral nerve crush. Exp Neurol 1986;92: 451-454.
8. Lipton JM: Neuropeptide alpha-melanocyte-stimulating hormone in control of fever, the acute phase response and inflammation; in Goetzl EJ, Spector NH (eds): Neuroimmune Networks. Physiology and Disease. New York, Liss, 1989, pp 243-250.
9. Schioth HB, Muceniece R, Wikberg JE, Chhajlani V: Characterization of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol 1995;288:311-317.
10. Haskell-Luevano C, Miwa H, Dickinson C, Hruby VJ, Yamada T, Gantz I: Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R. Biochem Biophys Res Commun 1994;204: 1137-1142.
11. Solca F, Siegrist W, Drozdz R, Girard J, Eberle AN: The receptor for alpha-melanotropin of mouse and human melanoma cells. Application of a potent alpha-melanotropin photoaffinity label. J Biol Chem 1989; 264:14277-14281.
12. Kameyama K, Tanaka S, Ishida Y, Hearing VJ: Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest 1989;83:213-221.
13. Zubair A, Lakshmi MS, Sherbet GV: Expression of alpha-melanocyte-stimulating hormone and the invasive ability of the B16 murine melanoma. Anticancer Res 1992;12: 399-402.
14. Saiki I, Murata J, Watanabe K, Fujii H, Abe F, Azuma I: Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro. Jpn J Cancer Res 1989;80:873-878.
15. Saiki I, Iida J, Murata J, Ogawa R, Nishi N, Sugimura K, Tokura S, Azuma I: Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Cancer Res 1989;49:3815-3822.
16. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
17. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM: Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1995;92: 8016-8020.
18. Sheppard JR, Lester B, Doll J, Buscarino C, Gonzales E, Corwin S, Greig S, Poste G: Biochemical regulation of adenylate cyclase in murine melanoma clones with different metastatic properties. Int J Cancer 1986;37:713-722.
19. Johnson GS, Morgan WD, Pastan I: Regulation of cell motility by cyclic AMP. Nature 1972;235:54-56.
20. Lampugnani MG, Giorgi M, Gaboli M, Dejana E, Marchisio PC: Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Lab Invest 1990;63:521-531.
21. Bennett DC, Dexter TJ, Ormerod EJ, Hart IR: Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. Cancer Res 1986;46: 3239-3244.
22. Kameyama K, Vieira WD, Tsukamoto K, Law LW, Hearing VJ: Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells. Int J Cancer 1990; 45:1151-1158.
23. Stoker M, Gherardi E: Regulation of cell movement: The motogenic cytokines. Biochim Biophys Acta 1991; 1072:81-102.
24. Qian F, Vaux DL, Weissman JL: Expression of the integrin α4β1 in melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994;77:335-347.
25. Goldfarb RH, Liotta LA: Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost 1986;12:294-307.
26. Schauer E, Trautinger F, Kock A, Schwarz A, Bhardwaj R, Simon M, Ansel JC, Schwarz T, Luger TA: Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994;93:2258-2262.